Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
1,110.341,110.371,117.241,097.84
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
620.54620.54622.67611.42
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
1,159.201,160.591,177.621,156.21
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
1,753.441,749.081,762.011,724.74
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
648.80649.58655.73643.68
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
832.49832.07833.09826.15
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
219.16219.16219.19214.82
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
3,113.363,120.793,143.643,105.16
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
926.67927.99930.54910.08
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
1,489.611,499.051,499.051,474.35
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
2,423.262,438.162,443.462,399.83
CCCC:NASDAQ
C4 Therapeutics, Inc
$3.12
+4.35%
(+0.13) 1D
$3.10
-0.64% (-0.020)
After hours
Closed: Apr 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CCCC...
Open
$2.98
High
$3.15
Low
$2.89
Mkt. cap
304.44M
Avg. vol.
2.99M
Volume
3.32M
52-wk high
$3.82
52-wk low
$1.20
EPS
-$1.27
Beta
2.85
Shares outstanding
97.58M
No. of employees
104
News stories
From sources across the web
About C4 Therapeutics, Inc
CEO-
Employees104
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Last report
Feb 26, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.18/ (-0.39 est.)USD
+54.24%beat
Revenue / Estimate
11.02M/ (4.48M est.)USD
+145.89%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
7.24M
6.46M
11.23M
11.02M
Cost of goods sold
27.07M
26.20M
25.99M
-70.28M
Cost of revenue
27.07M
26.20M
25.99M
-70.28M
Research and development expenses
-
-
-
95.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.33M
8.77M
8.92M
9.18M
Operating expense
9.33M
8.77M
8.92M
104.44M
Total operating expenses
36.40M
34.96M
34.91M
34.16M
Operating income
-29.16M
-28.50M
-23.68M
-23.14M
Other non operating income
-
-
-
-
EBT including unusual items
-26.32M
-26.02M
-32.17M
-20.36M
EBT excluding unusual items
-26.32M
-27.38M
-21.43M
-21.23M
Income tax expense
-
-
-
121.00K
Effective tax rate
-
-
-
-0.59%
Other operating expenses
-
-
-
-
Net income
-26.32M
-26.02M
-32.17M
-20.49M
Net profit margin
-363.66%
-402.60%
-286.43%
-185.97%
Earnings per share
-0.37
-0.37
-0.30
-0.18
Interest and investment income
2.84M
1.12M
2.25M
1.92M
Interest expense
-
-
-
-
Net interest expenses
2.84M
1.12M
2.25M
1.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.71M
-27.89M
-23.22M
-22.72M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more